[go: up one dir, main page]

DE60011149D1 - Klare wässrige anästhesierende zusammensetzung - Google Patents

Klare wässrige anästhesierende zusammensetzung

Info

Publication number
DE60011149D1
DE60011149D1 DE60011149T DE60011149T DE60011149D1 DE 60011149 D1 DE60011149 D1 DE 60011149D1 DE 60011149 T DE60011149 T DE 60011149T DE 60011149 T DE60011149 T DE 60011149T DE 60011149 D1 DE60011149 D1 DE 60011149D1
Authority
DE
Germany
Prior art keywords
anesthesic
composition
clear aqueous
aqueous
clear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60011149T
Other languages
English (en)
Other versions
DE60011149T2 (de
Inventor
Srikanth Pai
Sangeeta Rivankar
Shilpa Kocharekar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bharat Serums and Vaccines Ltd
Original Assignee
Bharat Serums and Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums and Vaccines Ltd filed Critical Bharat Serums and Vaccines Ltd
Publication of DE60011149D1 publication Critical patent/DE60011149D1/de
Application granted granted Critical
Publication of DE60011149T2 publication Critical patent/DE60011149T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60011149T 2000-06-21 2000-12-14 Klare wässrige anästhesierende zusammensetzung Expired - Lifetime DE60011149T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
INMU057300 2000-06-21
IN573MU2000 IN187686B (de) 2000-06-21 2000-06-21
PCT/IN2000/000124 WO2001097796A1 (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition

Publications (2)

Publication Number Publication Date
DE60011149D1 true DE60011149D1 (de) 2004-07-01
DE60011149T2 DE60011149T2 (de) 2005-07-07

Family

ID=11097257

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60011149T Expired - Lifetime DE60011149T2 (de) 2000-06-21 2000-12-14 Klare wässrige anästhesierende zusammensetzung

Country Status (26)

Country Link
US (1) US7138387B2 (de)
EP (1) EP1299095B1 (de)
JP (1) JP4907833B2 (de)
KR (1) KR100810066B1 (de)
CN (1) CN1254237C (de)
AP (1) AP2002002674A0 (de)
AT (1) ATE267592T1 (de)
AU (2) AU3597201A (de)
BG (1) BG107463A (de)
BR (1) BR0017268A (de)
CA (1) CA2414064C (de)
DE (1) DE60011149T2 (de)
DK (1) DK1299095T3 (de)
EA (1) EA005589B1 (de)
ES (1) ES2222271T3 (de)
HU (1) HUP0301646A3 (de)
IL (1) IL153387A0 (de)
IN (1) IN187686B (de)
MX (1) MXPA02012611A (de)
NO (1) NO20025999D0 (de)
NZ (1) NZ523643A (de)
PL (1) PL359624A1 (de)
PT (1) PT1299095E (de)
WO (1) WO2001097796A1 (de)
YU (1) YU2703A (de)
ZA (1) ZA200300336B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188917B (de) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
US7034013B2 (en) 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
BR0215303A (pt) * 2001-12-28 2005-04-05 Guilford Pharm Inc Formulações farmacêuticas de base aquosa de pró-drogas solúveis em água de propofol
DE60305438T2 (de) * 2002-02-01 2006-12-21 Shimoda Biotech (Pty.) Ltd., Mill Park Lyophilisierte pharmazeutische zusammensetzung von propofol
AU2003261274C1 (en) * 2002-07-29 2009-02-12 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
EP2359859A1 (de) * 2002-12-09 2011-08-24 Abraxis BioScience, LLC Zusammensetzungen, Albuminnanopartikel enthaltend und Methoden zur Freisetzung von Wirkstoffen
EP1704858A4 (de) * 2004-01-14 2008-06-04 Otsuka Pharma Co Ltd Propofol enthaltende fettemulsionszubereitung
BRPI0515181A (pt) * 2004-09-13 2008-07-22 Bharat Serums & Vaccines Ltd composição de óleo-em-água estéril para administração intravenosa, uso de um monoglicerìdeo e processo de preparação de uma composição para administração intravenosa
JP2009504634A (ja) * 2005-08-12 2009-02-05 ブハラット セルムズ アンド ヴァクシンズ リミテッド プロポフォールを含む水性麻酔剤組成物
WO2007128866A2 (en) * 2006-05-09 2007-11-15 Novobion Oy Novel chemical compositions
EP2269116A4 (de) * 2008-03-11 2011-09-07 3M Innovative Properties Co Fotowerkzeuge mit einer schutzschicht
WO2010148288A2 (en) * 2009-06-19 2010-12-23 Lyotropic Therapeutics, Inc. Pharmaceutical formulations with low aqueous levels of free unbound drug
EP2456823A4 (de) 2009-07-21 2012-12-26 3M Innovative Properties Co Härtbare zusammensetzung, verfahren zur beschichtung eines lichtwerkzeugs und beschichtetes lichtwerkzeug
EP2478033A1 (de) 2009-09-16 2012-07-25 3M Innovative Properties Company Fluorierte beschichtungen und damit hergestellte fotowerkzeuge
KR101768237B1 (ko) 2009-09-16 2017-08-14 쓰리엠 이노베이티브 프로퍼티즈 컴파니 플루오르화된 코팅 및 그로 제조된 포토툴
US8268067B2 (en) * 2009-10-06 2012-09-18 3M Innovative Properties Company Perfluoropolyether coating composition for hard surfaces
EP2345427A1 (de) * 2010-01-14 2011-07-20 SapioTec GmbH Flurankomplex
EP2484350B1 (de) * 2011-02-04 2016-04-20 Roewer, Norbert, Univ.-Prof. Dr. med. Pharmazeutische Zubereitung, enthaltend einen Komplex eines Propofolsalzes mit einem Cyclodextrin
SG11201401597TA (en) 2011-11-29 2014-05-29 Jurox Pty Ltd Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
AU2013273764B2 (en) * 2011-11-29 2016-05-05 Zoetis Services Llc Pharmaceutical compositions
CN103263404B (zh) * 2012-04-28 2017-12-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种复合麻醉药物
EP2887944B1 (de) 2012-08-21 2021-10-06 Sage Therapeutics, Inc. Allopregnanolon zur behandlung von refraktärem status epilepticus
WO2017132243A1 (en) * 2016-01-29 2017-08-03 Cuda Anesthetics, Llc Aqueous pharmaceutical formulation comprising propofol
FR3117337B1 (fr) 2020-12-10 2023-04-28 Centre Hospitalier Univ De Lille Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA962214B (en) * 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition

Also Published As

Publication number Publication date
BG107463A (en) 2003-11-28
EP1299095A1 (de) 2003-04-09
CN1454085A (zh) 2003-11-05
EA005589B1 (ru) 2005-04-28
MXPA02012611A (es) 2004-07-30
KR20030023875A (ko) 2003-03-20
IL153387A0 (en) 2003-07-06
JP2003535893A (ja) 2003-12-02
HUP0301646A2 (hu) 2003-09-29
IN187686B (de) 2002-06-08
AP2002002674A0 (en) 2002-12-31
ATE267592T1 (de) 2004-06-15
NZ523643A (en) 2004-05-28
PL359624A1 (en) 2004-08-23
WO2001097796A1 (en) 2001-12-27
CN1254237C (zh) 2006-05-03
YU2703A (sh) 2006-03-03
ES2222271T3 (es) 2005-02-01
US20040014718A1 (en) 2004-01-22
CA2414064A1 (en) 2001-12-27
NO20025999L (no) 2002-12-13
US7138387B2 (en) 2006-11-21
KR100810066B1 (ko) 2008-03-05
HUP0301646A3 (en) 2005-06-28
AU3597201A (en) 2002-01-02
EP1299095B1 (de) 2004-05-26
DK1299095T3 (da) 2004-10-11
AU2001235972B2 (en) 2005-07-21
NO20025999D0 (no) 2002-12-13
BR0017268A (pt) 2003-05-27
ZA200300336B (en) 2004-04-08
PT1299095E (pt) 2004-10-29
JP4907833B2 (ja) 2012-04-04
EA200300047A1 (ru) 2003-06-26
CA2414064C (en) 2013-01-08
DE60011149T2 (de) 2005-07-07

Similar Documents

Publication Publication Date Title
DE60011149D1 (de) Klare wässrige anästhesierende zusammensetzung
DE50104135D1 (de) Wässrige zusammensetzungen
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
PT1303521E (pt) Derivados de tetra-hidro-heterocicloazepinil-pirimidina
DK1280809T3 (da) Antitumorecteinascidinderivater
ATE298332T1 (de) Decahydro-isochinolinderivate
BR0013417B1 (pt) composiÇço aquosa.
DE50114491D1 (de) Substituierte C-Cyclohexylmethylamin-Derivative
DE60138100D1 (de) Wässrige beschichtungszusammensetzung
DE60103683D1 (de) Wässrige Pestizidzusammensetzung
DE60108008D1 (de) Wässrige Tintenzusammensetzung
AR028602A1 (es) Derivados de pirrol
AR028282A1 (es) Derivados de aminofenil pirimidona
ATE450652T1 (de) Wässrige zusammensetzung
DE60001302D1 (de) Wässrige Beschichtungszusammensetzung
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
DE50103035D1 (de) Substituierte 1-aminobutan-3-ol-derivate
BR0113783B1 (pt) Composição aquosa
DE60011924D1 (de) Ciclesonidhaltige wässrige arzneizusammensetzungen
BR0110478B1 (pt) composiÇço aquosa de xampu.
PT1246791E (pt) Derivados de aminometilfenilciclo-hexanona
DE60124839D1 (de) Wässrige Beschichtungszusammensetzung
DK1322590T3 (da) Substituerede 5-amino-1-penten-3-ol-derivater
ATE374776T1 (de) Pyrrolotriazolopyrimidinonderivate
DK1246793T3 (da) Substituerede aminomethyl-phenyl-cyclohexanderivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition